Gevo now expects non-GAAP adjusted EBITDA of more than $60 million for 2026, more than double its previous forecast of $30 million. Bloom said Gevo has sold approximately 17 million banked credits, which are expected to be recognized in the third quarter. He added that Gevo expects its 2027 adjusted EBITDA to be broadly in line with the updated 2026 target after accounting for nonrecurring 2026 revenue and production gains from debottlenecking. The company ended the quarter with $58 million in cash, cash equivalents and restricted cash. About Gevo (NASDAQ:GEVO)Gevo, Inc (NASDAQ: GEVO) is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products.